Outset Medical (OM) Fundamental Analysis: Revenue, Earnings & Valuation

0.36 / 10

Underperform

Fundamental analysis rates OM as Underperform, scoring only 0.4/10. Asset‑MV and Profit‑MV show modest strength, but Cash‑MV, Cash‑UP and ROE metrics are negative, indicating weak liquidity and profitability. Overall fundamentals are poor.

Analysis Checks(4/10)

ROA (%)

Value-30.23

Score1/3

Weight23.74%

1M Return-1.19%

Annualized return on equity (%)

Value-106.20

Score1/3

Weight39.30%

1M Return-2.02%

Profit-MV

Value0.68

Score2/3

Weight-79.31%

1M Return3.26%

Cash-UP

Value-0.16

Score2/3

Weight72.33%

1M Return-3.92%

Annualized net profit margin on total assets (%)

Value-30.23

Score1/3

Weight23.74%

1M Return-1.19%

ROE (diluted) (%)

Value-64.32

Score1/3

Weight27.55%

1M Return-1.41%

Asset-MV

Value-0.55

Score3/3

Weight-127.98%

1M Return4.79%

ROE (%)

Value-106.20

Score1/3

Weight39.30%

1M Return-2.02%

Cash-MV

Value0.03

Score1/3

Weight62.35%

1M Return-3.56%

Net profit / Total profit (%)

Value100.89

Score2/3

Weight18.96%

1M Return-0.89%

Is OM undervalued or overvalued?

OM scores 0.36/10 on fundamentals and holds a Premium valuation at present. Backed by its -106.20% ROE, -68.34% net margin, -0.79 P/E ratio, 0.51 P/B ratio, and 85.47% earnings growth, these metrics solidify its Underperform investment rating.